The epidemiology of endometrial cancer

Gynecologic Oncology

Volumn 41, Issue 1, 1991, Pages 1-16

  Parazzini, Fabio ^a   La Vecchia, Carlo ^a,b   Bocciolone, Luca ^a   Franceschi, Silvia ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; ENDOMETRIUM CARCINOMA; EPIDEMIOLOGY; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW;

FEMALE; HUMAN; INCIDENCE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; UTERINE NEOPLASMS;

EID: 0025728287     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(91)90246-2     Document Type: Review

References (118)

1. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today
2. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices
3. Age-related factors in cancers of the breast ovary and endometrium
4. Precursors of corpus I Estrogens and adenomatous hyperplasia
5. The Stein-Leventhal syndrome: Analysis of 43 cases with special reference to association with endometrial carcinoma
6. Endometrial adenocarcinoma in Stein-Leventhal syndrome
7. Endometrial adenocarcinoma and the Stein-Leventhal syndrome
8. Granulosa-theca cell tumors and endometrial carcinoma A study of their relationship and a survey of 80 cases
9. Benefits and risks of menopausal estrogen and/or progestin hormone use
10. Peripheral aromatization as a risk factor for breast and endometrial cancer in postmenopausal women: A review
11. Steroid hormones and endometrial cancer
12. The dose-effect relationship between “unopposed” oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
13. Population attributable risk for endometrial cancer in Northern Italy
14. Estimates of the world-wide frequency of sixteen major cancers in 1980
15. Cancer incidence in five continents V
16. Cancer incidence in five continents, III
17. The rising frequency of hysterectomy: Its effect on uterine cancer rates
18. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974–1986
19. Replacement estrogens and endometrial cancer
20. A case-control study of cancer of the endometrium
21. Epidemiology of endometrial cancer
22. Risk factors for endometrial cancer at different age
23. An epidemiological investigation of cancer of the endometrium
24. Patterns and determinants of conjugated estrogen use
25. Characteristics of noncontraceptive hormone users
26. Constitutional stigmas associated with endometrial carcinoma
27. Oestrogens and obesity as risk factors for endometrial cancer in Italy
28. Multistage models and primary prevention of cancer
29. Re-evaluating the role of progestogen therapy after the menopause
30. A case-control study of cancer of endometrium in Athens
31. Breast cancer risk assessed by anthropometry in the NHANES I epidemiological follow-up study
32. Body mass and prostatic cancer: A prospective study
33. Anthropometric indicators of endometrial cancer risk
34. Association between teen-age obesity and cancer in 56,111 women: all cancers and endometrial cancer
35. Variations in the reporting of menstrual histories
36. Endometrial carcinoma in young women
37. Reproductive factors and risk of cancer of the uterine corpus A prospective study
38. Combination oral contraceptive use and the risk of endometrial cancer
39. Parity and cancer risk in Slovakia
40. Reproductive factors and risk of endometrial cancer
41. Cancer risk after evaluation for infertility
42. Association of exogenous estrogen and endometrial carcinoma
43. Increased risk of endometrial carcinoma among users of conjugated estrogens
44. Estrogen and endometrial cancer: Cases and two control groups from North Carolina
45. A critique of the statistical evidence associating estrogens with endometrial cancer
46. Case-control study of oral contraceptive pills and endometrial cancer
47. Methodologic issues in epidemiologic studies of endometrial cancer and exogenous estrogen
48. Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy
49. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer
50. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium
51. Estrogens and endometrial carcinoma
52. Protection against endometrial carcinoma by combination-product oral contraceptives
53. The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous oestrogens
54. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium
55. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study
56. Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens
57. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
58. Tamoxifen as risk factor for carcinoma of corpus uteri
59. Tamoxifen and the uterus and endometrium
60. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse
61. On the epidemiology of oral contraceptives and disease
62. Increasing incidence of endometrial cancer in the United States
63. Decreased risk of endometrial cancer among oralcontraceptive users
64. Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies
65. Incidence of endometrial cancer in relation to the use of oral contraceptives
66. Oral contraceptive use and the risk of endometrial cancer
67. The epidemiology of endometrial cancer in young women
68. WHO Collaborative Study of Neoplasia and Steroid Contraceptives Endometrial cancer and combined oral contraceptives
69. Nutrient intakes in relation to cancer incidence in Hawaii
70. Diet and hormones in the epidemiology of breast and endometrial cancers
71. Nutrition and diet in the etiology of endometrial cancer
72. Diet and reproductive hormones: A study of vegetarian and nonvegetarian postmenopausal women
73. The influence of exercise training on plasma lipids and lipoproteins in health and disease
74. Brisk walking and plasma high density lipoprotein cholesterol concentration in previously sedentary women
75. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise
76. Effect of diabetic status on fractionated estrogen levels in postmenopausal women
77. Genesis of endometrial carcinoma
78. Smoking, body weight, and early-stage endometrial cancer
79. Cigarette smoking and the risk of female reproductive cancer
80. Relation between smoking and age of natural menopause
81. Osteoporosis of the slender smoker
82. Menopausal age in relation to smoking
83. Cigarette smoking and age at natural menopause
84. Cigarette smoking, relative weight, and menopause
85. Smoking and estrogen-related disease
86. Cigarette smoking and urinary estrogens
87. Pharmacological implications of microsomal enzyme induction
88. The antiestrogenic effect of cigarette smoking in women
89. Epidemiology
90. Variance estimators for attributable fraction estimates consistent in both large strata and sparse data
91. Cancer incidence in five continents
92. A controlled study of the constitutional stigmata of endometrial adenocarcinoma
93. Exogenous estrogen and endometrial carcinoma: Case-control and incidence study
94. Estrogen use: Risk of endometrial carcinoma
95. Risk of exogenous estrogen therapy and endometrial cancer
96. A novel approach to the analysis of risk factors in endometrial carcinoma
97. Endometrial cancer: How does cigarette smoking influence the risk of women under age 55 years having this tumor?
98. Cigarette smoking in women with cancers of the breast and reproductive organs
99. The joint effect of risk factors on endometrial cancer
100. Risk factors for endometrial cancer
101. Endocrine factors in endometrial carcinoma: A preliminary report
102. Adenocarcinoma of the endometrium in Israel, 1960–1968
103. Estrogens and endometrial cancer in a retirement community
104. Estrogen use and cancer of the uterine corpus in Alberta
105. Endometrial cancer and estrogen use: Report of a large case-control study
106. Conjugated estrogen use and risk of endometrial cancer
107. Endometrial cancer and patterns of use of oestrogen replacement therapy: A cohort study
108. Alternative analytic methods for case-control studies of estorgens and endometrial cancer
109. A prospective cohort study of oral contraceptives and cancer of the endometrium
110. Oral contraceptives and cancers of the breast and of the female genital tract: Interim results from a case-control study
111. The Cancer and Steroid Hormone Study Group: Postmenopausal smoking, estrogen replacement therapy, and the risk of endometrial cancer
112. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the Third National Cancer Survey
113. Cancer mortality in nonsmokers: Prospective study by the American Cancer Society
114. Effects of smoking on the development of female reproductive cancers
115. Cigarette smoking and the risk of endometrial cancer